NewAmsterdam Pharma NAMS Q1 2026 Earnings EPS Beat Reflects Cost Management Amid PreRevenue Phase KFY Q1 2026 Earnings EPS Beats Estimates Stock Rises 2 ICU Q1 2026 Earnings WiderthanExpected Loss as Company Remains PreRevenue ESRT Q1 2026 Earnings Positive EPS Amid Quiet Quarter INGM Q1 2026 Earnings EPS Beats Street Estimates Stock Moves Higher Accelerant Holdings Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction